coeptistx.com - Utang-utang marang kapitalisasi buku COEP

Lambang korporat lan logo Coeptis Therapeutics, Inc. (COEP)

The debt-to-equity ratio demonstrates financial stability, where 0.02 determines this parameter level. Coeptis Therapeutics (COEP) quotes depend on scientific publications, as commercial sales are absent. Innovations in NK-cell technology promise industrial scaling of blood cancer therapy. A team of elite oncologists is developing drugs, leveraging a modern infrastructure and a stable budget.

Coeptis Therapeutics Inc. - Utang-utang marang nilai buku COEP (periode 28.04.2023 - 09.05.2026)
Produk sing diprodhuksi coeptistx.com

This ratio reflects the level of financial leverage through the relationship between total liabilities and equity value. By analyzing the share of borrowed funds in the firm's book capitalization, an investor assesses the business's dependence on external financing. An increase in this metric signals rising credit risks and sensitivity to interest rates. Leverage stability is critical for Coeptis Therapeutics (COEP), which maintains costly biomaterial logistics. The flawless organization of raw material air freight requires a reliable financial foundation without excessive debt load.